EXOSC6: A Drug Target / Disease Biomarker (G118460)

Target Name: EXOSC6

NCBI ID: G118460

EXOSC6

EXOSC6: A Drug Target / Disease Biomarker

EXOSC6 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a key regulator of the exoskeleton, which is the outermost layer of cells in these organs. EXOSC6 plays a crucial role in the development and maintenance of the organization and structure of the exoskeleton, and is therefore of interest as a potential drug target or biomarker.

The exoskeleton is a complex structure that is essential for the support and protection of various physiological functions. It is made up of a series of rigid proteins that are arranged in a specific pattern to create a framework that can support and protect the body's various tissues. The exoskeleton is also involved in many of the body's movements and functions, such as walking, running, and eating.

EXOSC6 is a protein that is expressed in the exoskeleton of various organisms, including humans. It is a key regulator of the organization and structure of the exoskeleton, and is involved in the development and maintenance of the organization. EXOSC6 plays a crucial role in the regulation of cell division, cell signaling, and protein synthesis.

One of the key functions of EXOSC6 is its role in the regulation of cell division. EXOSC6 is involved in the development and maintenance of the cytoskeleton, which is the framework that surrounds each cell. The cytoskeleton is made up of a series of proteins that are arranged in a specific pattern to create a framework that can support and protect the cell. EXOSC6 plays a crucial role in the development and maintenance of the cytoskeleton by regulating the production and distribution of the cytoskeleton proteins.

EXOSC6 is also involved in the regulation of cell signaling. It is a key regulator of the cytoskeleton-associated protein (CAP) signaling pathway, which is involved in the regulation of cell growth, differentiation, and survival. EXOSC6 plays a crucial role in the regulation of CAP signaling by regulating the production and distribution of CAP proteins.

EXOSC6 is also involved in the regulation of protein synthesis. It is a key regulator of the translation of mRNAs, which are the templates for protein synthesis. EXOSC6 plays a crucial role in the regulation of translation by regulating the production and distribution of ribosomes, which are the machines that synthesize proteins.

In addition to its role in cell division, signaling, and protein synthesis, EXOSC6 is also involved in the regulation of many other cellular processes. It is a key regulator of the cell cycle, which is the process by which cells grow, divide, and replicate their genetic material. EXOSC6 plays a crucial role in the regulation of the cell cycle by regulating the production and distribution of the proteins that are involved in the cell cycle.

EXOSC6 is also involved in the regulation of the cytoskeleton-associated protein (CAP) signaling pathway, which is involved in the regulation of cell growth, differentiation, and survival. EXOSC6 plays a crucial role in the regulation of CAP signaling by regulating the production and distribution of CAP proteins.

In conclusion, EXOSC6 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a key regulator of the exoskeleton, and is therefore of interest as a potential drug target or biomarker. EXOSC6 plays a crucial role in the regulation of cell division, signaling, protein synthesis, and many other cellular processes. Its regulation of the exoskeleton is a crucial function that allows it to support and protect the body's various tissues. Further research is needed to fully understand the role of EXOSC6 as a drug target or biomarker.

Protein Name: Exosome Component 6

Functions: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes

The "EXOSC6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EXOSC6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets